Undas A - Search Results

1

Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.

Musiał J, Pajak A, Undas A, Kawalec E, Topór-Madry R, Pazucha T, Grzywacz M, Szczeklik A. Musiał J, et al. Among authors: undas a. Thromb Haemost. 1997 Apr;77(4):697-700. Thromb Haemost. 1997. PMID: 9134645 Clinical Trial.

2

Plasma fibrinolytic activity in healthy subjects with high and low lipoprotein(a) concentrations.

Szczeklik A, Radwan J, Kubicka A, Libura M, Sacha T, Swadźba J, Undas A, Szczeklik J, Jodlowski J. Szczeklik A, et al. Among authors: undas a. Thromb Res. 1992 May 15;66(4):391-5. doi: 10.1016/0049-3848(92)90288-l. Thromb Res. 1992. PMID: 1412205 No abstract available.

3

[High levels of cholesterol and lipoprotein (A) in serum decreases the inhibitory effect of aspirin on generation of thrombin].

Szczeklik A, Musiał J, Undas A, Swadźba J, Duplaga M, Grzywacz M. Szczeklik A, et al. Among authors: undas a. Pol Arch Med Wewn. 1995 Jun;93(6):483-9. Pol Arch Med Wewn. 1995. PMID: 7491348 Polish.

4

Interferon-gamma in the treatment of atopic dermatitis: influence on T-cell activation.

Musiał J, Milewski M, Undas A, Kopinski P, Duplaga M, Szczeklik A. Musiał J, et al. Among authors: undas a. Allergy. 1995 Jun;50(6):520-3. doi: 10.1111/j.1398-9995.1995.tb01190.x. Allergy. 1995. PMID: 7573848 Clinical Trial.

5

[Human recombinant interferon gamma in the treatment of atopic dermatitis].

Musiał J, Milewski M, Undas A, Kopiński P, Duplaga M, Szczeklik A. Musiał J, et al. Among authors: undas a. Pol Arch Med Wewn. 1994 Dec;92(6):499-506. Pol Arch Med Wewn. 1994. PMID: 7716053 Polish.

6

[Lipid metabolism abnormalities and atherosclerosis in patients on maintenance hemodialysis].

Musiał J, Undas A, Sysło K. Musiał J, et al. Among authors: undas a. Przegl Lek. 1994;51(6):264-7. Przegl Lek. 1994. PMID: 7938663 Review. Polish.

7

Thrombinogenesis and its pharmacological modulation in atherosclerosis.

Szczeklik A, Musiał J, Dropiński J, Krzanowski M, Królikowski W, Undas A, Swadźba J, Duplaga M, Bodzoń W. Szczeklik A, et al. Among authors: undas a. J Physiol Pharmacol. 1994 Mar;45(1):3-11. J Physiol Pharmacol. 1994. PMID: 8043909 Review.

8

Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.

Gluszko P, Undas A, Amenta S, Szczeklik A, Schmaier AH. Gluszko P, et al. Among authors: undas a. J Lab Clin Med. 1994 Feb;123(2):232-40. J Lab Clin Med. 1994. PMID: 8301199 Clinical Trial.

9

Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.

Szczeklik A, Musial J, Undas A, Swadzba J, Gora PF, Piwowarska W, Duplaga M. Szczeklik A, et al. Among authors: undas a. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):948-54. doi: 10.1161/01.atv.16.8.948. Arterioscler Thromb Vasc Biol. 1996. PMID: 8696958

10

Gamma interferon administration to patients with atopic dermatitis inhibits fibrinolysis and elevates C1 inhibitor.

Musial J, Gluszko P, Undas A, Mahdi F, Kang S, Szczeklik A, Schmaier AH. Musial J, et al. Among authors: undas a. Thromb Res. 1998 Mar 15;89(6):253-61. doi: 10.1016/s0049-3848(98)00016-4. Thromb Res. 1998. PMID: 9669747 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

700 results

Search Page

Filters